BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) financials

BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]

Market Cap: ₹49.1Cr.
Current Price: ₹30.2
Stock P/E: 102
ROE: -2.83%
ROCE: 2.97%
Book Value: ₹13.2
Dividend Yield: 0.00%
52W High / Low: ₹46.8/25.6

In Jun 2026, BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) reported sales ₹12.35 Cr and net profit ₹0.11 Cr.

Annual TTM: sales ₹34.32 Cr, net profit ₹0.48 Cr.

Shareholding: Promoters 46.79% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.08% (Sep 2026), Public 53.13% (Sep 2026), No. of Shareholders 24,660% (Sep 2026).

BIOFILCHEM quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	2.41	14.20	8.35	6.43	13.54	0.86	7.57	12.35
Expenses	2.29	13.89	8.24	6.42	13.42	0.77	7.14	12.21
Operating Profit	0.12	0.31	0.11	0.01	0.12	0.09	0.43	0.14
OPM %	4.98%	2.18%	1.32%	0.16%	0.89%	10.47%	5.68%	1.13%
Other Income	0.02	0.02	0.24	2.83	0.06	0.08	0.11	0.06
Interest	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Depreciation	0.10	0.10	0.08	0.07	0.07	0.07	0.07	0.07
Profit before tax	0.03	0.22	0.26	2.76	0.11	0.10	0.47	0.13
Tax %	33.33%	27.27%	23.08%	12.68%	27.27%	30.00%	55.32%	23.08%
Net Profit	0.02	0.16	0.20	2.41	0.08	0.08	0.21	0.11
EPS in Rs	0.01	0.10	0.12	1.48	0.05	0.05	0.13	0.07
Raw PDF	—	—	—	—	—	—	—	—

BIOFILCHEM profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	29.69	35.75	22.38	30.04	40.04	33.40	28.40	34.32
Expenses	27.87	34.15	21.05	28.88	39.23	32.55	27.75	33.54
Operating Profit	1.82	1.60	1.33	1.16	0.81	0.85	0.65	0.78
OPM %	6.13%	4.48%	5.94%	3.86%	2.02%	2.54%	2.29%	2.27%
Other Income	0.17	0.80	0.15	0.10	0.49	0.31	3.08	0.31
Interest	0.12	0.07	0.04	0.04	0.04	0.04	0.01	0.00
Depreciation	0.41	0.41	0.43	0.43	0.40	0.38	0.27	0.28
Profit before tax	1.46	1.92	1.01	0.79	0.86	0.74	3.45	0.81
Tax %	17.81%	34.90%	31.68%	29.11%	17.44%	24.32%	19.13%	—
Net Profit	1.21	1.24	0.70	0.56	0.71	0.56	2.79	0.48
EPS in Rs	0.74	0.76	0.43	0.34	0.44	0.34	1.71	0.30
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

BIOFILCHEM balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27
Reserves	-2.62	-1.39	-0.14	0.56	1.03	1.93	2.51	5.29
Borrowings	1.64	1.19	0.43	0.46	0.52	0.44	0.47	3.02
Other Liabilities	8.93	26.30	16.68	1.44	13.58	28.44	31.70	18.26
Total Liabilities	24.22	42.37	33.24	18.73	31.40	47.08	50.95	42.84
Fixed Assets	10.29	10.09	9.78	9.42	9.00	8.62	8.34	6.94
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	13.93	32.28	23.46	9.31	22.40	38.46	42.61	35.90
Total Assets	24.22	42.37	33.24	18.73	31.40	47.08	50.95	42.84

BIOFILCHEM cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	1.26	0.89	1.11	-0.22	-0.11	2.39	-1.92	-0.60
Cash from Investing Activity	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02	-0.10	1.14
Cash from Financing Activity	-0.08	-0.57	-0.83	-0.01	0.02	-0.12	0.00	2.54
Net Cash Flow	-0.24	0.12	0.18	-0.30	-0.11	2.25	-2.03	3.07
Free Cash Flow	-0.15	0.68	1.01	-0.29	-0.12	2.37	-2.02	0.54
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	134%	63%	112%	8%	10%	314%	-205%	9%

BIOFILCHEM shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	46.82%	46.82%	46.82%	46.79%	46.79%	46.79%	46.79%	46.79%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%
Public	53.11%	53.11%	53.10%	53.12%	53.13%	53.12%	53.13%	53.13%
No. of Shareholders	26,114	25,914	25,685	25,196	24,825	25,356	24,999	24,660

BIOFILCHEM key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	189.84	365.25	175.81	116.94	249.08	301.10	418.77	354.59
Inventory Days	21.73	24.37	48.85	24.20	16.11	24.81	39.52	56.24
Days Payable	156.66	373.80	178.39	11.25	168.39	268.08	366.66	239.87
Cash Conversion Cycle	54.90	15.82	46.27	129.88	96.80	57.83	91.63	170.96
Working Capital Days	50.81	55.69	64.12	125.25	104.25	69.37	114.09	152.17
ROCE %	5.00%	10.08%	12.20%	6.20%	4.73%	4.94%	4.12%	2.97%

BIOFILCHEMUpdated 18 Oct 2026, 0:59

Biofil Chem & Pharma Ltd

BIOFILCHEMUpdated 18 Oct 2026, 0:59

Market Cap

₹49.1Cr.

Current Price

₹30.2

High / Low

₹46.8/25.6

Stock P/E

102

ROE-2.83%

ROCE2.97%

Book Value₹13.2

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	2.43	0.01	2.01	0.02	0.11	0.32	25	0.24	0.15
Sep 2023	17.37	0.01	17.13	0.03	0.11	0.15	20	0.12	0.07
Dec 2023	5.03	0	4.84	0.03	0.11	0.11	18.18	0.09	0.06
Mar 2024	15.2	0.02	15.24	0.41	0.08	0.27	11.11	0.25	0.15
Jun 2024	8.44	0.01	8.13	0.03	0.1	0.23	26.09	0.17	0.1
Sep 2024	2.41	0.01	2.29	0.02	0.1	0.03	33.33	0.02	0.01
Dec 2024	14.2	0.01	13.89	0.02	0.1	0.22	27.27	0.16	0.1
Mar 2025	8.35	0.01	8.24	0.24	0.08	0.26	23.08	0.2	0.12
Jun 2025	6.43	0.01	6.42	2.83	0.07	2.76	12.68	2.41	1.48
Sep 2025	13.54	0	13.42	0.06	0.07	0.11	27.27	0.08	0.05
Dec 2025	0.86	0	0.77	0.08	0.07	0.1	30	0.08	0.05
Mar 2026	7.57	0	7.14	0.11	0.07	0.47	55.32	0.21	0.13
Jun 2026	12.35	0	12.21	0.06	0.07	0.13	23.08	0.11	0.07

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	5.86	0.21	5.12	0.46	0.25	0.74	20.27	0.59	0.36
Mar 2016	13.17	0.15	12.3	0.53	0.26	0.99	20.2	0.78	0.48
Mar 2017	13.45	0.16	10.84	0.14	0.28	2.31	22.51	1.79	1.1
Mar 2018	12.36	0.15	11.43	0.1	0.3	0.58	20.69	0.47	0.29
Mar 2019	23.13	0.16	22.11	0.1	0.37	0.59	20.34	0.48	0.29
Mar 2020	29.69	0.12	27.87	0.17	0.41	1.46	17.81	1.21	0.74
Mar 2021	35.75	0.07	34.15	0.8	0.41	1.92	34.9	1.24	0.76
Mar 2022	22.38	0.04	21.05	0.15	0.43	1.01	31.68	0.7	0.43
Mar 2023	30.04	0.04	28.88	0.1	0.43	0.79	29.11	0.56	0.34
Mar 2024	40.04	0.04	39.23	0.49	0.4	0.86	17.44	0.71	0.44
Mar 2025	33.4	0.04	32.55	0.31	0.38	0.74	24.32	0.56	0.34
Mar 2026	28.4	0.01	27.75	3.08	0.27	3.45	19.13	2.79	1.71
TTM	34.32	0	33.54	0.31	0.28	0.81	—	0.48	0.3

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	46.79%
DIIs	0.08%
Public	53.13%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	46.82%	0%	0.08%	53.11%
Mar 2024	46.82%	0.03%	0.08%	53.08%
Jun 2024	46.82%	0%	0.08%	53.11%
Sep 2024	46.82%	0%	0.08%	53.1%
Dec 2024	46.82%	0%	0.08%	53.11%
Mar 2025	46.82%	0%	0.08%	53.11%
Jun 2025	46.82%	0%	0.08%	53.1%
Sep 2025	46.79%	0%	0.08%	53.12%
Dec 2025	46.79%	0%	0.08%	53.13%
Mar 2026	46.79%	0%	0.08%	53.12%
Jun 2026	46.79%	0%	0.08%	53.13%
Sep 2026	46.79%	0%	0.08%	53.13%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	Other Assets	Total Assets
Mar 2015	16.27	-7.86	2.98	2.36	13.75	9.06	4.69	13.75
Mar 2016	16.27	-5.37	1.37	11.87	24.14	8.98	15.16	24.14
Mar 2017	16.27	-3.58	1.43	7.72	21.84	9.16	12.68	21.84
Mar 2018	16.27	-3.11	1.56	9.44	24.16	9.25	14.91	24.16
Mar 2019	16.27	-2.62	1.64	8.93	24.22	10.29	13.93	24.22
Mar 2020	16.27	-1.39	1.19	26.3	42.37	10.09	32.28	42.37
Mar 2021	16.27	-0.14	0.43	16.68	33.24	9.78	23.46	33.24
Mar 2022	16.27	0.56	0.46	1.44	18.73	9.42	9.31	18.73
Mar 2023	16.27	1.03	0.52	13.58	31.4	9	22.4	31.4
Mar 2024	16.27	1.93	0.44	28.44	47.08	8.62	38.46	47.08
Mar 2025	16.27	2.51	0.47	31.7	50.95	8.34	42.61	50.95
Mar 2026	16.27	5.29	3.02	18.26	42.84	6.94	35.9	42.84

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	0.01	-0.17	0.11	-0.05
Mar 2016	0.14	-0.19	0.1	0.05
Mar 2017	0.71	-0.48	-0.11	0.13
Mar 2018	0.46	-0.38	-0.02	0.06
Mar 2019	1.26	-1.41	-0.08	-0.24
Mar 2020	0.89	-0.21	-0.57	0.12
Mar 2021	1.11	-0.1	-0.83	0.18
Mar 2022	-0.22	-0.07	-0.01	-0.3
Mar 2023	-0.11	-0.01	0.02	-0.11
Mar 2024	2.39	-0.02	-0.12	2.25
Mar 2025	-1.92	-0.1	0	-2.03
Mar 2026	-0.6	1.14	2.54	3.07

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	227.35	387.45	311.00	383.31	189.84	365.25	175.81	116.94	249.08	301.10	418.77	354.59
Inventory Days	15.99	3.46	7.29	38.11	21.73	24.37	48.85	24.20	16.11	24.81	39.52	56.24
Days Payable	198.49	400.98	304.52	341.46	156.66	373.80	178.39	11.25	168.39	268.08	366.66	239.87
Cash Conversion Cycle	44.85	-10.07	13.76	79.95	54.90	15.82	46.27	129.88	96.80	57.83	91.63	170.96
Working Capital Days	-47.96	48.50	87.65	104.83	50.81	55.69	64.12	125.25	104.25	69.37	114.09	152.17
ROCE %	8.59%	9.64%	18.72%	5.06%	5.00%	10.08%	12.20%	6.20%	4.73%	4.94%	4.12%	2.97%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of BIOFIL CHEM & PHARMA LTD (BIOFILCHEM)?

The reported market capitalisation for BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) is ₹49.1Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of BIOFILCHEM?

The current price shown for BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) on Fincrux is ₹30.2 with a 52-week high/low of ₹46.8/25.6.

What is the P/E ratio of BIOFIL CHEM & PHARMA LTD (BIOFILCHEM)?

The stock P/E for BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) is 102 on Fincrux, with ROE at -2.83% and ROCE at 2.97%.

What were BIOFILCHEM latest quarterly results?

For Jun 2026, BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) reported sales ₹12.35 Cr and net profit ₹0.11 Cr (figures in ₹ crore unless noted).

What are BIOFILCHEM annual sales and net profit?

For TTM, BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) shows sales of ₹34.32 Cr and net profit of ₹0.48 Cr on the Fincrux profit & loss statement.

Who owns BIOFIL CHEM & PHARMA LTD (BIOFILCHEM)?

Latest shareholding for BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) on Fincrux: Promoters 46.79% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.08% (Sep 2026), Public 53.13% (Sep 2026), No. of Shareholders 24,660% (Sep 2026).

Where can I find BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) financials?

BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show BIOFILCHEM balance sheet and cash flow?

Yes. The BIOFIL CHEM & PHARMA LTD (BIOFILCHEM) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 0:59